nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study
|
Christophersen, Ingrid E. |
|
2016 |
178 |
C |
p. 45-54 10 p. |
artikel |
2 |
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial
|
Åkerblom, Axel |
|
2016 |
178 |
C |
p. 1-8 8 p. |
artikel |
3 |
Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry
|
Harrison, Robert W. |
|
2016 |
178 |
C |
p. 95-101 7 p. |
artikel |
4 |
Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in “The World of AVATAR”
|
Dominguez-Rodriguez, Alberto |
|
2016 |
178 |
C |
p. e1- 1 p. |
artikel |
5 |
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
|
Vemulapalli, Sreekanth |
|
2016 |
178 |
C |
p. 74-84 11 p. |
artikel |
6 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti
|
Malebranche, Rodolphe |
|
2016 |
178 |
C |
p. 151-160 10 p. |
artikel |
7 |
Defining nonvalvular atrial fibrillation: A quest for clarification
|
Martins, Raphaël P. |
|
2016 |
178 |
C |
p. 161-167 7 p. |
artikel |
8 |
Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE)
|
DeVore, Adam D. |
|
2016 |
178 |
C |
p. 198-205 8 p. |
artikel |
9 |
Editorial Board
|
|
|
2016 |
178 |
C |
p. A5- 1 p. |
artikel |
10 |
Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial
|
Armaganijan, Luciana V. |
|
2016 |
178 |
C |
p. 176-184 9 p. |
artikel |
11 |
Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study
|
O'Donnell, Martin J. |
|
2016 |
178 |
C |
p. 145-150 6 p. |
artikel |
12 |
Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial
|
Tabbalat, Ramzi A. |
|
2016 |
178 |
C |
p. 102-107 6 p. |
artikel |
13 |
Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study
|
Johnston, Nina |
|
2016 |
178 |
C |
p. 85-94 10 p. |
artikel |
14 |
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
|
Ridker, Paul M. |
|
2016 |
178 |
C |
p. 135-144 10 p. |
artikel |
15 |
Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
|
Kaul, Padma |
|
2016 |
178 |
C |
p. 55-64 10 p. |
artikel |
16 |
Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement
|
Kiramijyan, Sarkis |
|
2016 |
178 |
C |
p. 19-27 9 p. |
artikel |
17 |
Information for Readers
|
|
|
2016 |
178 |
C |
p. A6- 1 p. |
artikel |
18 |
In response to Letter to the Editor
|
Chan, Maya L. |
|
2016 |
178 |
C |
p. e7- 1 p. |
artikel |
19 |
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
|
Lip, Gregory Y.H. |
|
2016 |
178 |
C |
p. 126-134 9 p. |
artikel |
20 |
Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease
|
Fröhlich, Hanna |
|
2016 |
178 |
C |
p. 28-36 9 p. |
artikel |
21 |
Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model?
|
Allen, Larry A. |
|
2016 |
178 |
C |
p. 188-189 2 p. |
artikel |
22 |
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial
|
Camaro, Cyril |
|
2016 |
178 |
C |
p. 37-44 8 p. |
artikel |
23 |
Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study
|
Rao, Chenfei |
|
2016 |
178 |
C |
p. 9-18 10 p. |
artikel |
24 |
Reactive hyperemia is associated with adverse clinical outcomes in heart failure
|
Paine, Nicola J. |
|
2016 |
178 |
C |
p. 108-114 7 p. |
artikel |
25 |
Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in “the world of AVATAR”
|
Banovic, Marko |
|
2016 |
178 |
C |
p. e3-e4 nvt p. |
artikel |
26 |
Risky business: Personalizing the approach to percutaneous coronary intervention
|
Rothberg, Michael B. |
|
2016 |
178 |
C |
p. 185-187 3 p. |
artikel |
27 |
Table of Contents
|
|
|
2016 |
178 |
C |
p. A1-A4 nvt p. |
artikel |
28 |
The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry–Get With the Guidelines (GWTG) Medicare-linked database
|
Sutton, Nadia R. |
|
2016 |
178 |
C |
p. 65-73 9 p. |
artikel |
29 |
Time course, predictors, and prognostic implications of significant mitral regurgitation after ST-segment elevation myocardial infarction
|
Abate, Elena |
|
2016 |
178 |
C |
p. 115-125 11 p. |
artikel |
30 |
To the Editor
|
Mohammad, Rami |
|
2016 |
178 |
C |
p. e5- 1 p. |
artikel |
31 |
Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention
|
Decker, Carole |
|
2016 |
178 |
C |
p. 190-197 8 p. |
artikel |
32 |
Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial
|
Selker, Harry P. |
|
2016 |
178 |
C |
p. 168-175 8 p. |
artikel |